Viser 321 bedrifter for "Pharmaceuticals"
Bedrifter
Novo Nordisk A/S
Novo Nordisk er et globalt legemiddelselskap med fokus på behandling av diabetes, fedme og andre alvorlige kroniske sykdommer. De tilbyr innovative medisiner og leveringssystemer, og innehar en ledende posisjon innen diabetesbehandling. Selskapet er engasjert i bærekraftig utvikling og pasienttilgang.
ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Abbott er et globalt helseteknologiselskap som er forpliktet til å hjelpe mennesker med å leve bedre liv gjennom helsens kraft. De tilbyr en diversifisert portefølje av ledende, vitenskapsbaserte produkter innen diagnostikk, medisinsk utstyr, ernæring og generiske legemidler med merkenavn. Abbott er ledende innen diabetesbehandling med FreeStyle Libre, og er dedikert til å forbedre helseresultater over hele verden.
ABBOTT NORGE AS
Abbott er et helseselskap dedikert til å hjelpe mennesker med å leve sunnere liv. De utvikler innovative helseteknologier og -produkter, inkludert verktøy for diabetesbehandling, kardiovaskulære enheter, diagnostikk og ernæringsprodukter. Med over 135 års erfaring opererer Abbott i over 160 land og sysselsetter over 114 000 mennesker, med mål om å forbedre helseresultater globalt.
PFIZER INC
Pfizer is a leading biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines and vaccines. The company's portfolio includes a wide range of treatments for areas like oncology, vaccines, and immunology. Pfizer is recognized for its global reach and commitment to improving patient health.
ASTRAZENECA PLC
AstraZeneca is a global pharmaceutical company that researches, develops, and commercializes prescription medicines. They focus on therapy areas such as oncology, biopharmaceuticals, and rare diseases. AstraZeneca is known for its science-led approach and commitment to improving health worldwide.
Sanofi
Sanofi is an R&D-driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth. They focus on developing breakthrough innovations in medicines and vaccines, with expertise in immunology, oncology, and rare diseases. The company has a global presence and emphasizes sustainable and equitable access to healthcare. Sanofi strives to pursue the miracles of science so people can chase their dreams.
INCYTE CORP
Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies. They are particularly known for their products in oncology and dermatology. The company has achieved significant progress in addressing unmet medical needs.
NOVARTIS AG
Novartis is a global healthcare company focused on discovering, developing and commercializing innovative medicines. They aim to improve and extend people’s lives by addressing significant unmet medical needs with a broad portfolio of pharmaceuticals, including treatments for oncology, immunology, and other therapeutic areas. With a commitment to ethical behavior and corporate responsibility, Novartis integrates ESG principles into its business practices.
Merck & Co., Inc.
We are a premier research-intensive biopharmaceutical company delivering innovative health solutions. We focus on the prevention and treatment of diseases in people and animals through leading-edge science. For over 130 years, we've developed important medicines and vaccines, aiming to save and improve lives globally. We foster inclusivity for a safe, sustainable future.
Yakult Honsha Co., LTD/ADR
Yakult Honsha Co., Ltd. is a global company focused on contributing to the health and happiness of people around the world. They are best known for their probiotic dairy products, especially Yakult, a fermented milk drink containing *Lactobacillus casei* strain Shirota. Additionally, they offer a range of other food products, cosmetics, and pharmaceuticals, with a strong emphasis on research and development.
REGENERON PHARMACEUTICALS, INC.
Regeneron is a biopharmaceutical company driven by scientific breakthroughs to create life-changing medicines for people with serious diseases. They focus on innovative solutions from biologics to genetic medicines. Their efforts redefine excellence and efficiency in research and development.
GSK plc
GSK unites science, technology, and talent to get ahead of disease. They focus on research and development within therapeutic areas like respiratory, immunology, oncology, and HIV. The company has a strong global presence and is committed to improving access to healthcare.
Novo Nordisk Research Center Gladsaxe ApS
Novo Nordisk is a global healthcare company focused on discovering and developing innovative medicines to help people living with serious chronic diseases, primarily diabetes and obesity. They offer a range of pharmaceutical products and devices, including insulin and GLP-1 receptor agonists. Novo Nordisk holds a leading position in diabetes care and is committed to driving change to defeat other serious chronic conditions.
BION ENVIRONMENTAL TECHNOLOGIES INC
BioNTech is a global immunotherapy powerhouse aspiring to translate science into survival. They focus on developing drugs for cancer and infectious diseases by harnessing the full potential of the immune system. BioNTech is dedicated to improving the health of people worldwide through fundamental research and development of immunotherapies and mRNA vaccines.
ALNYLAM PHARMACEUTICALS, INC.
Alnylam Pharmaceuticals is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics. They develop and commercialize medicines for genetic diseases. Their key products target rare diseases. Alnylam is a leader in RNAi technology, with a growing portfolio of approved therapies.
SERVIER OUTRE-MER
Servier er et uavhengig, internasjonalt farmasøytisk selskap med fokus på terapeutiske fremskritt for pasienter. De investerer betydelig i forskning og utvikling, særlig innen onkologi, kardiometabolisme og nevrovitenskap. Servier er kjent for sin langsiktige visjon og forpliktelse til pasientenes behov.
DR REDDYS LABORATORIES LTD
This company focuses on providing affordable and innovative medicines. Key areas include generics, API & services, innovative medicines, and consumer health solutions. They are expanding their portfolio through in-licensing and partnerships. The company aims to improve patient access to treatments and operate globally with a strong commitment to integrity and quality.
KAMADA LTD
Kamada is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. It boasts a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities. The company drives profitable growth from commercial activities and expertise in the plasma-derived biopharmaceutical market. Noteworthy products include GLASSIA®, KEDRAB®, CYTOGAM®, HEPAGAM B®, VARIZIG® and WINRHO®SDF.
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals is dedicated to advancing science to improve the lives of individuals, with an initial focus on hereditary angioedema (HAE). They are developing orally-delivered small molecule medicines to transform the HAE treatment landscape and address unmet patient needs. Their goal is to make a meaningful difference for people living with HAE by offering new possibilities for disease management. KalVista's lead product is an oral on-demand treatment for HAE.
Roivant Sciences Ltd.
Roivant develops transformative medicines and technologies by building agile, focused companies called Vants. They have conducted 12 positive Phase 3 trials since 2019 and launched VTAMA® for the treatment of plaque psoriasis. The company focuses on rapidly advancing and commercializing important medicines.